(Q44256625)

English

Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

Elisabeth Sanders

6

object named as

Elisabeth A M Sanders

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Richarda M de Voer

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Fiona R M van der Klis

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Carla W A M Engels

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rutger M Schepp

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jan van de Kassteele

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ger T Rijkers

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Guy A M Berbers

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

6974-6982

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Circulating antibody secreting cells and humoral antibody response after parenteral immunization with a meningococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Immunological memory in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Maintenance of serological memory by polyclonal activation of human memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Vaccination against encapsulated bacteria in humans: paradoxes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.082

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.09.082

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44256625&oldid=2108943946"